Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date

RATIONALE: Aggressive pituitary adenomas and pituitary carcinomas are rare and demand multiple treatment strategies. Temozolomide, an orally active alkylating chemotherapeutic agent, has recently been recommended as a salvage medication for refractory pituitary adenomas or carcinomas. PATIENT CONCER...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Yin, Senlin, Zhang, Shizhen, Wang, Mengmeng, Hu, Yu, Zhou, Peizhi, Jiang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708963/
https://www.ncbi.nlm.nih.gov/pubmed/29381964
http://dx.doi.org/10.1097/MD.0000000000008733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708963/
https://www.ncbi.nlm.nih.gov/pubmed/29381964
http://dx.doi.org/10.1097/MD.0000000000008733

Ejemplares similares